Dr. Etta Pisano at UNC is optimistic about the use of the Mi-Co technology in the clinical trial setting. "Mi-Co's technology is very exciting because it will make participation in clinical trials easier and more acceptable to very busy clinicians. The digital writing techniques we have been testing are much easier to use than a keyboard and mouse. In addition, these techniques will provide more accurate data because of the system's ability to check for data errors throughout the process from data capture to data communication." "The entire project team is truly excited about this award. We will see the entire system working in a very demanding environment because of FDA regulations for clinical trials software and processes and the very high data quality standards of the ACRIN organization," said Dr. Greg Clary, Principal Investigator and CTO at Mi-Co. (MarketWire)